Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
Neuropsychiatric Disease and Treatment|June 21, 2018
Initiating/maintaining long-acting injectable antipsychotics in schizophrenia/schizoaffective or bipolar disorder - expert consensus survey part 2Martha Sajatovic, Ruth Ross, Susan N Legacy, et al.
Neuropsychiatric Disease and Treatment|June 21, 2018
Identifying patients and clinical scenarios for use of long-acting injectable antipsychotics - expert consensus survey part 1Martha Sajatovic, Ruth Ross, Susan N Legacy, et al.
Pharmacological Research|November 22, 2017
Enantiomer-specific positive allosteric modulation of CB<sub>1</sub> signaling in autaptic hippocampal neuronsJose Mitjavila, Danielle Yin, Pushkar M Kulkarni, et al.
Behavioural Pharmacology|October 31, 2014
Modulation of food consumption and sleep-wake cycle in mice by the neutral CB1 antagonist ABD459Anushka V Goonawardena, Andrea Plano, Lianne Robinson, et al.
The Journal of Clinical Psychiatry|February 8, 2011
Efficacy and safety of loxapine for inhalation in the treatment of agitation in patients with schizophrenia: a randomized, double-blind, placebo-controlled trialMichael H Allen, David Feifel, Michael D Lesem, et al.
Experimental Eye Research|September 17, 2020
Evidence that cannabinoid CB1 receptors regulate intraocular pressure via two opposing mechanismsSally Miller, Laura Daily, Maya Ploss, et al.
Molecules (Basel, Switzerland)|April 27, 2024
CB1 Receptor Negative Allosteric Modulators as a Potential Tool to Reverse Cannabinoid ToxicityAudrey Flavin, Paniz Azizi, Natalia Murataeva, et al.
FEBS Letters|January 13, 2006
First "hybrid" ligands of vanilloid TRPV1 and cannabinoid CB2 receptors and non-polyunsaturated fatty acid-derived CB2-selective ligandsGiovanni Appendino, Maria Grazia Cascio, Sara Bacchiega, et al.
CNS Spectrums|October 27, 2005
Best clinical practice with ziprasidone IM: update after 2 years of experienceDan L Zimbroff, Michael H Allen, John Battaglia, et al.
European Journal of Medicinal Chemistry|May 31, 2016
A critical review of both the synthesis approach and the receptor profile of the 8-chloro-1-(2',4'-dichlorophenyl)-N-piperidin-1-yl-1,4,5,6-tetrahydrobenzo[6,7]cyclohepta[1,2-c]pyrazole-3-carboxamide and analogue derivativesPaolo Lazzari, Rita Distinto, Ilaria Manca, et al.
Pageof 4